Indication

COVID-19

COVID-19 (coronavirus disease 2019) is an acute infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targeting the respiratory system but capable of causing multiorgan pathology. Read more about COVID-19

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common COVID-19 therapies.

Showing 1–3 of 3 drugs

VEKLURY (remdesivir)

COVID-19 (SARS-COV-2) ANTIVIRAL AGENTS-NUCLEOTIDE ANALOG·COVID-19
GILEAD SCIENCES
Filter & compare in the drug finder →Opens the drug finder with COVID-19 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About COVID-19.

COVID-19 (coronavirus disease 2019) is an acute infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targeting the respiratory system but capable of causing multiorgan pathology.

The disease affects pediatric and adult populations, with older adults and individuals with underlying medical comorbidities experiencing the greatest risk of severe disease.

Pathophysiologically, the condition is driven by viral replication followed, in severe presentations, by a dysregulated systemic inflammatory response, endothelial injury, and coagulopathy.

Clinical manifestations range from asymptomatic infection or mild upper respiratory symptoms—such as fever, cough, fatigue, and anosmia—to acute hypoxemic respiratory failure, acute respiratory distress syndrome (ARDS), thromboembolic events, and death.

Personalize your experience

Follow COVID-19 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it